MedTrace Logo

Stool Testing for Pancreatic Cancer

NCT01104129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2021-01-19

No results posted yet for this study

Summary

The purpose of this study is to determine if pancreatic cancer/pre-cancer can be detected in early stages through the molecular analysis of stool samples. Investigators hypothesize that analysis of stool samples using digital melt curve (DMC) analysis, can be used as a sensitive and specific method to detect the common genetic abnormalities present in pancreatic cancers and pre-cancerous lesions of the pancreas.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Wendy K Chung, MD · Columbia University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-09
Primary Completion
2016-11-29
Completion
2016-11-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104129 on ClinicalTrials.gov